S30 A Phase 2b Study to Evaluate the Efficacy and Safety of Investigational Microbiome Therapeutic SER-287 in Mildly-to-Moderately Active UC

Brian Feagan; David Rubin; Stephen Hanauer; William Sandborn; Shiraz Farooq; Henry Levine; Caterina Oneto; David Lichter; Gabrielle Glick; Kelly Brady; Barbara McGovern; Sherry Wang-Weigand; Mark Sostek; Lisa Grier; David Kerman; Bharat Misra; Kenolisa Onwueme; Jeffrey Axler; Lisa von Moltke

doi:10.14309/01.ajg.0000897628.50103.7d

Back

S30 A Phase 2b Study to Evaluate the Efficacy and Safety of Investigational Microbiome Therapeutic SER-287 in Mildly-to-Moderately Active UC

Journal article

Peer reviewed

S30 A Phase 2b Study to Evaluate the Efficacy and Safety of Investigational Microbiome Therapeutic SER-287 in Mildly-to-Moderately Active UC

Brian Feagan, David Rubin, Stephen Hanauer, William Sandborn, Shiraz Farooq, Henry Levine, Caterina Oneto, David Lichter, Gabrielle Glick, Kelly Brady, …

The American journal of gastroenterology, Vol.117(12S), pp.S8-S8

2022-12

DOI: https://doi.org/10.14309/01.ajg.0000897628.50103.7d

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

Details

Title: S30 A Phase 2b Study to Evaluate the Efficacy and Safety of Investigational Microbiome Therapeutic SER-287 in Mildly-to-Moderately Active UC
Creators: Brian Feagan - Western University
David Rubin - University of Chicago
Stephen Hanauer - Northwestern University
William Sandborn - University of California San Diego
Shiraz Farooq - GCP Clinical Research, Tampa, Florida, United States
Henry Levine - Troy Gastroenterology
Caterina Oneto - Vanguard
David Lichter - Seres Therapeutics
Gabrielle Glick - Seres Therapeutics
Kelly Brady - Seres Therapeutics
Barbara McGovern - Seres Therapeutics
Sherry Wang-Weigand - Seres Therapeutics
Mark Sostek - Seres Therapeutics
Lisa Grier - Seres Therapeutics
David Kerman - University of Miami
Bharat Misra - Borland Groover Clinic
Kenolisa Onwueme - Woodholme Gastroenterology Associates, Glen burnie, Maryland, United States
Jeffrey Axler - Toronto Digestive Disease Associates, Toronto, Canada
Lisa von Moltke - Seres Therapeutics
Publication Details: The American journal of gastroenterology, Vol.117(12S), pp.S8-S8
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Gastroenterology
Language: English
Resource Type: Journal article
Record Identifier: 991032860895002976